AZBio President & CEO, Joan Koerber-Walker provides a brief overview of the provision of the Inflation Reduction act of 2022 (The IRA) from the patient and health innovation perspective and is then joined by health innovator and drug developer, Dr. Steven J. Potts, for a discussion of the potential unintended consequences of some provisions of The IRA relating to the future health innovation landscape.
The IRA is now law. What comes next?
SUMMARY: THE INFLATION REDUCTION ACT OF 2022
STATE FACT SHEETS: How the Inflation Reduction Act Lowers Health Care Costs Across America
Explaining the Prescription Drug Provisions in the Inflation Reduction Act
H.R.5376 – Inflation Reduction Act of 2022
Public Law: Full Text